Login / Signup

PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery.

Hiroshi NakagomiMasayuki InoueYosuke HirotsuKenji AmemiyaHitoshi MochidukiMasao Omata
Published in: Breast cancer research and treatment (2022)
Genome profiling revealed that abnormalities in the PIK3CA-AKT pathway in long-term residential recurrences and are a crucial molecular group in the development of IBTR.
Keyphrases